Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats

The derivatives of phenytoin (DPH) were synthesized by the reaction at 3 position of hydantoin ring with valproic acid and valeric acid, producing valproyl DPH (VPDPH) and valeroyl DPH (VADPH), respectively. These derivatives showed much higher lipid solubilities than that of DPH. Their distribution...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological & pharmaceutical bulletin 1993/10/15, Vol.16(10), pp.1025-1030
Hauptverfasser: OGISO, Taro, IWAKI, Masahiro, TANINO, Tadatoshi, MURAOKA, Osamu, TANABE, Genzou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1030
container_issue 10
container_start_page 1025
container_title Biological & pharmaceutical bulletin
container_volume 16
creator OGISO, Taro
IWAKI, Masahiro
TANINO, Tadatoshi
MURAOKA, Osamu
TANABE, Genzou
description The derivatives of phenytoin (DPH) were synthesized by the reaction at 3 position of hydantoin ring with valproic acid and valeric acid, producing valproyl DPH (VPDPH) and valeroyl DPH (VADPH), respectively. These derivatives showed much higher lipid solubilities than that of DPH. Their distribution and elimination were compared to those of DPH. Additionally, the concentration profiles of the drugs in brain and plasma were analyzed with a modified 2-compartment model. DPH and its derivatives, without hydrolysis to DPH in blood, were found rapidly distributed into brain, although the distribution of derivatives was much less, probably due to the high protein binding capacities. The distribution of DPH and its derivatives into brain regions was similar to that into the cortex cerebri. VPDPH and VADPH were more rapidly eliminated from plasma and brain than DPH, giving smaller mean residence time (MRT) values (0.92 and 0.85 h) and much smaller cortex/plasma concentration ratio than those of DPH. The VPDPH and VADPH concentrations in the cerebrospinal fluid (CSF) were also much lower than that of DPH. The time course of plasma and brain concentrations of DPH and its derivatives after i.v. administration was successfully described by the modified 2-compartment models presented.
doi_str_mv 10.1248/bpb.16.1025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76172427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3120242011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c608t-12ffe8de1db5b5ee8ef38a8e99161d7d336d567e204c9bd37b774cb7c28b37563</originalsourceid><addsrcrecordid>eNpdkc1rGzEQxUVpSJ20p54LCy29lHU10upjj2maNIFATGnOQtLONnL3w5HWAf_30dauD4VBA_N-zENvCHkPdAms0l_dxi1BLoEy8YosgFeqFAzEa7KgNehSgtBvyFlKa0qpooyfklPNtKKcLcjD6tHG3vrxTxhwCr64GGy3SyEVY1usHnHYTWMYCjs0xe2Uiu8Yw7OdwjOmIo9XnU29_at-izYPcv20U3pLTlrbJXx36Ofk4frq1-VNeXf_4_by4q70kuqpBNa2qBuExgknEDW2XFuNdQ0SGtVwLhshFTJa-do1XDmlKu-UZ9pxJSQ_J5_3ezdxfNpimkwfkseuswOO22SUBMUqpjL48T9wPW5j_moyUFU1iIrDTH3ZUz6OKUVszSaG3sadAWrmqE2O2oA0c9SZ_nDYuXU9Nkf2kG3WPx10m7zt2mgHH9IR47Wiks3Y9R5bp8n-xqNuYz5Hh7Ml1DXf2_57s_8R8PmCBgf-AiZunZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449154317</pqid></control><display><type>article</type><title>Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>OGISO, Taro ; IWAKI, Masahiro ; TANINO, Tadatoshi ; MURAOKA, Osamu ; TANABE, Genzou</creator><creatorcontrib>OGISO, Taro ; IWAKI, Masahiro ; TANINO, Tadatoshi ; MURAOKA, Osamu ; TANABE, Genzou</creatorcontrib><description>The derivatives of phenytoin (DPH) were synthesized by the reaction at 3 position of hydantoin ring with valproic acid and valeric acid, producing valproyl DPH (VPDPH) and valeroyl DPH (VADPH), respectively. These derivatives showed much higher lipid solubilities than that of DPH. Their distribution and elimination were compared to those of DPH. Additionally, the concentration profiles of the drugs in brain and plasma were analyzed with a modified 2-compartment model. DPH and its derivatives, without hydrolysis to DPH in blood, were found rapidly distributed into brain, although the distribution of derivatives was much less, probably due to the high protein binding capacities. The distribution of DPH and its derivatives into brain regions was similar to that into the cortex cerebri. VPDPH and VADPH were more rapidly eliminated from plasma and brain than DPH, giving smaller mean residence time (MRT) values (0.92 and 0.85 h) and much smaller cortex/plasma concentration ratio than those of DPH. The VPDPH and VADPH concentrations in the cerebrospinal fluid (CSF) were also much lower than that of DPH. The time course of plasma and brain concentrations of DPH and its derivatives after i.v. administration was successfully described by the modified 2-compartment models presented.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.16.1025</identifier><identifier>PMID: 8287032</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>Animals ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Brain - metabolism ; brain distribution ; Injections, Intravenous ; Male ; Medical sciences ; Models, Biological ; modified 2-compartment model ; Neuropharmacology ; pharmacokinetic analysis ; Pharmacology. Drug treatments ; Phenytoin - analogs &amp; derivatives ; Phenytoin - chemical synthesis ; Phenytoin - pharmacokinetics ; Rats ; Rats, Wistar ; valeroyl phenytoin ; valpropyl phenytoin</subject><ispartof>Biological and Pharmaceutical Bulletin, 1993/10/15, Vol.16(10), pp.1025-1030</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1994 INIST-CNRS</rights><rights>Copyright Japan Science and Technology Agency 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c608t-12ffe8de1db5b5ee8ef38a8e99161d7d336d567e204c9bd37b774cb7c28b37563</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3970622$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8287032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OGISO, Taro</creatorcontrib><creatorcontrib>IWAKI, Masahiro</creatorcontrib><creatorcontrib>TANINO, Tadatoshi</creatorcontrib><creatorcontrib>MURAOKA, Osamu</creatorcontrib><creatorcontrib>TANABE, Genzou</creatorcontrib><title>Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats</title><title>Biological &amp; pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>The derivatives of phenytoin (DPH) were synthesized by the reaction at 3 position of hydantoin ring with valproic acid and valeric acid, producing valproyl DPH (VPDPH) and valeroyl DPH (VADPH), respectively. These derivatives showed much higher lipid solubilities than that of DPH. Their distribution and elimination were compared to those of DPH. Additionally, the concentration profiles of the drugs in brain and plasma were analyzed with a modified 2-compartment model. DPH and its derivatives, without hydrolysis to DPH in blood, were found rapidly distributed into brain, although the distribution of derivatives was much less, probably due to the high protein binding capacities. The distribution of DPH and its derivatives into brain regions was similar to that into the cortex cerebri. VPDPH and VADPH were more rapidly eliminated from plasma and brain than DPH, giving smaller mean residence time (MRT) values (0.92 and 0.85 h) and much smaller cortex/plasma concentration ratio than those of DPH. The VPDPH and VADPH concentrations in the cerebrospinal fluid (CSF) were also much lower than that of DPH. The time course of plasma and brain concentrations of DPH and its derivatives after i.v. administration was successfully described by the modified 2-compartment models presented.</description><subject>Animals</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>brain distribution</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>modified 2-compartment model</subject><subject>Neuropharmacology</subject><subject>pharmacokinetic analysis</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenytoin - analogs &amp; derivatives</subject><subject>Phenytoin - chemical synthesis</subject><subject>Phenytoin - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>valeroyl phenytoin</subject><subject>valpropyl phenytoin</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1rGzEQxUVpSJ20p54LCy29lHU10upjj2maNIFATGnOQtLONnL3w5HWAf_30dauD4VBA_N-zENvCHkPdAms0l_dxi1BLoEy8YosgFeqFAzEa7KgNehSgtBvyFlKa0qpooyfklPNtKKcLcjD6tHG3vrxTxhwCr64GGy3SyEVY1usHnHYTWMYCjs0xe2Uiu8Yw7OdwjOmIo9XnU29_at-izYPcv20U3pLTlrbJXx36Ofk4frq1-VNeXf_4_by4q70kuqpBNa2qBuExgknEDW2XFuNdQ0SGtVwLhshFTJa-do1XDmlKu-UZ9pxJSQ_J5_3ezdxfNpimkwfkseuswOO22SUBMUqpjL48T9wPW5j_moyUFU1iIrDTH3ZUz6OKUVszSaG3sadAWrmqE2O2oA0c9SZ_nDYuXU9Nkf2kG3WPx10m7zt2mgHH9IR47Wiks3Y9R5bp8n-xqNuYz5Hh7Ml1DXf2_57s_8R8PmCBgf-AiZunZw</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>OGISO, Taro</creator><creator>IWAKI, Masahiro</creator><creator>TANINO, Tadatoshi</creator><creator>MURAOKA, Osamu</creator><creator>TANABE, Genzou</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><general>Japan Science and Technology Agency</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats</title><author>OGISO, Taro ; IWAKI, Masahiro ; TANINO, Tadatoshi ; MURAOKA, Osamu ; TANABE, Genzou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c608t-12ffe8de1db5b5ee8ef38a8e99161d7d336d567e204c9bd37b774cb7c28b37563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>brain distribution</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>modified 2-compartment model</topic><topic>Neuropharmacology</topic><topic>pharmacokinetic analysis</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenytoin - analogs &amp; derivatives</topic><topic>Phenytoin - chemical synthesis</topic><topic>Phenytoin - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>valeroyl phenytoin</topic><topic>valpropyl phenytoin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OGISO, Taro</creatorcontrib><creatorcontrib>IWAKI, Masahiro</creatorcontrib><creatorcontrib>TANINO, Tadatoshi</creatorcontrib><creatorcontrib>MURAOKA, Osamu</creatorcontrib><creatorcontrib>TANABE, Genzou</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological &amp; pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OGISO, Taro</au><au>IWAKI, Masahiro</au><au>TANINO, Tadatoshi</au><au>MURAOKA, Osamu</au><au>TANABE, Genzou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats</atitle><jtitle>Biological &amp; pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>1993</date><risdate>1993</risdate><volume>16</volume><issue>10</issue><spage>1025</spage><epage>1030</epage><pages>1025-1030</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>The derivatives of phenytoin (DPH) were synthesized by the reaction at 3 position of hydantoin ring with valproic acid and valeric acid, producing valproyl DPH (VPDPH) and valeroyl DPH (VADPH), respectively. These derivatives showed much higher lipid solubilities than that of DPH. Their distribution and elimination were compared to those of DPH. Additionally, the concentration profiles of the drugs in brain and plasma were analyzed with a modified 2-compartment model. DPH and its derivatives, without hydrolysis to DPH in blood, were found rapidly distributed into brain, although the distribution of derivatives was much less, probably due to the high protein binding capacities. The distribution of DPH and its derivatives into brain regions was similar to that into the cortex cerebri. VPDPH and VADPH were more rapidly eliminated from plasma and brain than DPH, giving smaller mean residence time (MRT) values (0.92 and 0.85 h) and much smaller cortex/plasma concentration ratio than those of DPH. The VPDPH and VADPH concentrations in the cerebrospinal fluid (CSF) were also much lower than that of DPH. The time course of plasma and brain concentrations of DPH and its derivatives after i.v. administration was successfully described by the modified 2-compartment models presented.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>8287032</pmid><doi>10.1248/bpb.16.1025</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-6158
ispartof Biological and Pharmaceutical Bulletin, 1993/10/15, Vol.16(10), pp.1025-1030
issn 0918-6158
1347-5215
language eng
recordid cdi_proquest_miscellaneous_76172427
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Animals
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Brain - metabolism
brain distribution
Injections, Intravenous
Male
Medical sciences
Models, Biological
modified 2-compartment model
Neuropharmacology
pharmacokinetic analysis
Pharmacology. Drug treatments
Phenytoin - analogs & derivatives
Phenytoin - chemical synthesis
Phenytoin - pharmacokinetics
Rats
Rats, Wistar
valeroyl phenytoin
valpropyl phenytoin
title Pharmacokinetic Analysis of Phenytoin and Its Derivatives in Plasma and Brain in Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A14%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetic%20Analysis%20of%20Phenytoin%20and%20Its%20Derivatives%20in%20Plasma%20and%20Brain%20in%20Rats&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=OGISO,%20Taro&rft.date=1993&rft.volume=16&rft.issue=10&rft.spage=1025&rft.epage=1030&rft.pages=1025-1030&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.16.1025&rft_dat=%3Cproquest_cross%3E3120242011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1449154317&rft_id=info:pmid/8287032&rfr_iscdi=true